Castle Biosciences (CSTL) News Today $21.62 +0.20 (+0.93%) Closing price 04:00 PM EasternExtended Trading$21.62 +0.00 (+0.02%) As of 05:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CSTL Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Caxton Associates LLP Buys Shares of 16,440 Castle Biosciences, Inc. $CSTLSeptember 15 at 3:50 AM | marketbeat.comJacobs Levy Equity Management Inc. Sells 113,483 Shares of Castle Biosciences, Inc. $CSTLSeptember 15 at 3:19 AM | marketbeat.comCastle Biosciences, Inc. $CSTL Shares Purchased by Advisors Capital Management LLCSeptember 14 at 5:07 AM | marketbeat.comCastle Biosciences, Inc. $CSTL Holdings Raised by Acadian Asset Management LLCSeptember 14 at 4:57 AM | marketbeat.comCastle Biosciences (NASDAQ:CSTL) Receives "Buy" Rating from Canaccord Genuity GroupSeptember 11, 2025 | marketbeat.comCastle Biosciences' (CSTL) Buy Rating Reiterated at Canaccord Genuity GroupSeptember 11, 2025 | americanbankingnews.comCastle Biosciences Shows Improved Relative Price Performance; Still Shy Of BenchmarkSeptember 10, 2025 | msn.comNew Data at American Foregut Society's 2025 Annual Meeting Demonstrates TissueCypher® Can Detect High-Risk Barrett’s Esophagus Patients Not Identified by Pathology to ...September 9, 2025 | markets.businessinsider.comNew Data at American Foregut Society's 2025 Annual Meeting Demonstrates TissueCypher® Can Detect High-Risk Barrett's Esophagus Patients Not Identified by Pathology to Support Improved Care DecisionsSeptember 9, 2025 | globenewswire.com556,485 Shares in Castle Biosciences, Inc. $CSTL Bought by Park West Asset Management LLCSeptember 8, 2025 | marketbeat.comCastle Biosciences, Inc. $CSTL Shares Acquired by Parkman Healthcare Partners LLCSeptember 8, 2025 | marketbeat.comCubist Systematic Strategies LLC Has $4.76 Million Stock Position in Castle Biosciences, Inc. $CSTLSeptember 7, 2025 | marketbeat.comCastle Biosciences, Inc. (NASDAQ:CSTL) Receives $37.00 Consensus PT from BrokeragesSeptember 7, 2025 | americanbankingnews.comGraham Capital Management L.P. Purchases 26,709 Shares of Castle Biosciences, Inc. $CSTLSeptember 5, 2025 | marketbeat.comMagnetar Financial LLC Purchases New Stake in Castle Biosciences, Inc. $CSTLSeptember 5, 2025 | marketbeat.comCastle Biosciences, Inc. (NASDAQ:CSTL) Receives Average Recommendation of "Moderate Buy" from AnalystsSeptember 5, 2025 | marketbeat.comBraidwell LP Acquires New Shares in Castle Biosciences, Inc. $CSTLSeptember 3, 2025 | marketbeat.comTrexquant Investment LP Increases Stock Holdings in Castle Biosciences, Inc. $CSTLSeptember 3, 2025 | marketbeat.comCastle Biosciences: Strong Margins, Solid Balance Sheet, And Big Upside PotentialSeptember 2, 2025 | seekingalpha.comRussell Investments Group Ltd. Raises Position in Castle Biosciences, Inc. $CSTLSeptember 2, 2025 | marketbeat.comCastle Biosciences (NASDAQ:CSTL) Upgraded by Zacks Research to Hold RatingAugust 31, 2025 | marketbeat.comCastle Biosciences, Inc. $CSTL Shares Sold by Charles Schwab Investment Management Inc.August 31, 2025 | marketbeat.com15,287 Shares in Castle Biosciences, Inc. $CSTL Acquired by Quantbot Technologies LPAugust 30, 2025 | marketbeat.comCastle Biosciences, Inc. $CSTL Shares Purchased by Wellington Management Group LLPAugust 29, 2025 | marketbeat.comVanguard Group Inc. Acquires 215,030 Shares of Castle Biosciences, Inc. $CSTLAugust 29, 2025 | marketbeat.comCastle Biosciences announces publication of two studies on DecisionDx-SCC testAugust 25, 2025 | msn.comCastle Biosciences' DecisionDx-SCC Outperforms Current Staging Systems in Predicting Risk for High-Risk Cutaneous Squamous Cell CarcinomaAugust 25, 2025 | quiverquant.comQNew Evidence Published Supporting Use of DecisionDx®-SCC Test in Guiding and Improving Treatment Pathway Decisions in NCCN High-Risk Cutaneous Squamous Cell CarcinomaAugust 25, 2025 | globenewswire.comAdvantage Alpha Capital Partners LP Invests $396,000 in Castle Biosciences, Inc. $CSTLAugust 24, 2025 | marketbeat.comNuveen LLC Invests $13.45 Million in Castle Biosciences, Inc. $CSTLAugust 24, 2025 | marketbeat.comCastle Biosciences to Participate in Upcoming Investor ConferencesAugust 21, 2025 | globenewswire.comCastle Biosciences Updates Bylaws for Improved GovernanceAugust 12, 2025 | theglobeandmail.comCastle Biosciences’ Earnings Call: Growth Amid ChallengesAugust 12, 2025 | theglobeandmail.comCastle Biosciences (NASDAQ:CSTL) Raised to "Hold" at Wall Street ZenAugust 11, 2025 | marketbeat.comCastle Biosciences, Inc. (NASDAQ:CSTL) Given Consensus Recommendation of "Buy" by AnalystsAugust 11, 2025 | marketbeat.comXTX Topco Ltd Invests $393,000 in Castle Biosciences, Inc. (NASDAQ:CSTL)August 10, 2025 | marketbeat.comLeerink Partnrs Issues Optimistic Forecast for CSTL EarningsAugust 8, 2025 | marketbeat.comCastle Biosciences, Inc. (NASDAQ:CSTL) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | msn.comCastle Biosciences (NASDAQ:CSTL) Shares Gap Up Following Strong EarningsAugust 6, 2025 | marketbeat.comCastle Biosciences (NASDAQ:CSTL) Posts Earnings Results, Beats Expectations By $0.59 EPSAugust 5, 2025 | marketbeat.comCastle Biosciences Reports Strong Q2 2025 Financial ResultsAugust 5, 2025 | msn.comCastle Biosciences raises FY25 revenue view to $310M-$320M from $287M-$297MAugust 5, 2025 | msn.comCastle Biosciences, Inc. (CSTL) Q2 2025 Earnings Call TranscriptAugust 4, 2025 | seekingalpha.comCastle (CSTL) Q2 Revenue Tops EstimatesAugust 4, 2025 | fool.comCastle Biosciences Reports Second Quarter 2025 ResultsAugust 4, 2025 | globenewswire.comExamining the Future: Castle Biosciences's Earnings OutlookAugust 1, 2025 | benzinga.comCastle Biosciences to Present at the Canaccord Genuity 45th Annual Growth ConferenceJuly 29, 2025 | globenewswire.comCastle Biosciences (CSTL) to Release Earnings on MondayJuly 28, 2025 | marketbeat.comCastle Biosciences (NASDAQ:CSTL) shareholders have endured a 58% loss from investing in the stock five years agoJuly 27, 2025 | finance.yahoo.comCerity Partners LLC Buys Shares of 21,138 Castle Biosciences, Inc. (NASDAQ:CSTL)July 27, 2025 | marketbeat.com Get Castle Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CSTL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CSTL Media Mentions By Week CSTL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CSTL News Sentiment▼1.060.94▲Average Medical News Sentiment CSTL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CSTL Articles This Week▼115▲CSTL Articles Average Week Get the Latest News and Ratings for CSTL and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Castle Biosciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Veracyte News Heartflow News Celcuity News LifeStance Health Group News Addus HomeCare News Progyny News Ardent Health News National HealthCare News Aveanna Healthcare News PACS Group News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CSTL) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Castle Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Castle Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CSTL Stock Alerts